203 related articles for article (PubMed ID: 26918447)
1. PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells.
Symonds JM; Ohm AM; Tan AC; Reyland ME
Oncotarget; 2016 Apr; 7(14):17905-19. PubMed ID: 26918447
[TBL] [Abstract][Full Text] [Related]
2. Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
Ohm AM; Tan AC; Heasley LE; Reyland ME
Oncogene; 2017 Jul; 36(30):4370-4378. PubMed ID: 28368426
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.
Symonds JM; Ohm AM; Carter CJ; Heasley LE; Boyle TA; Franklin WA; Reyland ME
Cancer Res; 2011 Mar; 71(6):2087-97. PubMed ID: 21335545
[TBL] [Abstract][Full Text] [Related]
4. ERβ regulates NSCLC phenotypes by controlling oncogenic RAS signaling.
Nikolos F; Thomas C; Rajapaksa G; Bado I; Gustafsson JÅ
Mol Cancer Res; 2014 Jun; 12(6):843-54. PubMed ID: 24618619
[TBL] [Abstract][Full Text] [Related]
5. Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.
Hood JD; Frausto R; Kiosses WB; Schwartz MA; Cheresh DA
J Cell Biol; 2003 Sep; 162(5):933-43. PubMed ID: 12952943
[TBL] [Abstract][Full Text] [Related]
6. Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
Shi S; Zhang J; Liu M; Dong H; Li N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2343-2351. PubMed ID: 31184227
[TBL] [Abstract][Full Text] [Related]
7. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
8. K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.
Koo KH; Jeong WJ; Cho YH; Park JC; Min do S; Choi KY
Oncotarget; 2015 Aug; 6(25):21328-40. PubMed ID: 26015399
[TBL] [Abstract][Full Text] [Related]
9. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
Ly DP; Corbett SA
J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
[TBL] [Abstract][Full Text] [Related]
10. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
11. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
[TBL] [Abstract][Full Text] [Related]
12. Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer.
Yoon S; Yang H; Ryu HM; Lee E; Jo Y; Seo S; Kim D; Lee CH; Kim W; Jung KH; Park SR; Choi EK; Kim SW; Park KS; Lee DH
Cancer Res Treat; 2022 Jul; 54(3):767-781. PubMed ID: 34607394
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites.
Han S; Roman J
Int J Cancer; 2005 Sep; 116(4):536-46. PubMed ID: 15825163
[TBL] [Abstract][Full Text] [Related]
14. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression.
Zheng Y; Ritzenthaler JD; Roman J; Han S
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):681-90. PubMed ID: 17600315
[TBL] [Abstract][Full Text] [Related]
15. Loss of beta1-integrin enhances TGF-beta1-induced collagen expression in epithelial cells via increased alphavbeta3-integrin and Rac1 activity.
Hayashida T; Jones JC; Lee CK; Schnaper HW
J Biol Chem; 2010 Oct; 285(40):30741-51. PubMed ID: 20650890
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
[TBL] [Abstract][Full Text] [Related]
18. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme.
Kanamori M; Vanden Berg SR; Bergers G; Berger MS; Pieper RO
Cancer Res; 2004 Apr; 64(8):2751-8. PubMed ID: 15087390
[TBL] [Abstract][Full Text] [Related]
19. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
20. Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis.
Muras AG; Hajj GN; Ribeiro KB; Nomizo R; Nonogaki S; Chammas R; Martins VR
Int J Cancer; 2009 Oct; 125(7):1523-31. PubMed ID: 19444918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
